Aditxt (NASDAQ:ADTX) Announces Earnings Results

Aditxt (NASDAQ:ADTX) posted its quarterly earnings data on Wednesday. The company reported $999.00 earnings per share (EPS) for the quarter, reports. Aditxt had a negative net margin of 1,217,927.00% and a negative return on equity of 374.60%.

Aditxt Stock Performance

Shares of NASDAQ:ADTX opened at $1.40 on Thursday. The company’s 50-day moving average is $18.60 and its 200 day moving average is $273.37. The company has a market capitalization of $42,000.00, a P/E ratio of 0.00 and a beta of 1.08. Aditxt has a fifty-two week low of $1.34 and a fifty-two week high of $53,451.08.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.